<DOC>
	<DOCNO>NCT01977924</DOCNO>
	<brief_summary>Severe obstructive sleep apnea ( OSA ) associate increased cardiovascular morbidity mortality . Endothelial dysfunction , early marker vascular disease demonstrate OSA . Regular treatment OSA continuous positive airway pressure ( CPAP ) improve endothelial function associate reduction cardiovascular risk . Approximately 40 % patient OSA intolerant insufficiently adherent CPAP . Alternative treatment adjuvant CPAP need . The polyphenols demonstrate effectiveness improve endothelial function patient CV disease . No randomized control study evaluate impact PPR endothelial dysfunction associate OSAHS .</brief_summary>
	<brief_title>Impact Polyphenols Endothelial Function Obstructive Sleep Apnea</brief_title>
	<detailed_description>The endpoint change one month polyphenols treatment endothelial function measure index hyperemic reactivity . The secondary endpoint change one month supplementation polyphenols ambulatory blood pressure measurement 24 hour ( MAPA ) , micro-circulatory responsiveness , speed pulse wave biological measurement ( lipid profile , blood glucose , fast insulin , leptin , adiponectin , hs-CRP , 8-isoprostane level cellular origin microparticles ) .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>â€¢ apnea hypopnea index &gt; 30 accepting polyphenols supplementation Signed informed consent Epworth sleepiness scale &gt; 16/24 Severe cardiac and/or respiratory disease BMI &gt; 35 kg/m2 Anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>sleep apnea</keyword>
	<keyword>polyphenols</keyword>
	<keyword>endothelial function</keyword>
</DOC>